KR101616187B1 - Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus - Google Patents
Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus Download PDFInfo
- Publication number
- KR101616187B1 KR101616187B1 KR1020140074824A KR20140074824A KR101616187B1 KR 101616187 B1 KR101616187 B1 KR 101616187B1 KR 1020140074824 A KR1020140074824 A KR 1020140074824A KR 20140074824 A KR20140074824 A KR 20140074824A KR 101616187 B1 KR101616187 B1 KR 101616187B1
- Authority
- KR
- South Korea
- Prior art keywords
- gaba
- fermentation
- omija
- lactic acid
- msg
- Prior art date
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title claims abstract description 123
- 229960003692 gamma aminobutyric acid Drugs 0.000 title claims abstract description 62
- 238000000034 method Methods 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title abstract description 17
- 235000019985 fermented beverage Nutrition 0.000 title description 6
- 241000186660 Lactobacillus Species 0.000 title description 2
- 240000006079 Schisandra chinensis Species 0.000 title description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 title description 2
- 229940039696 lactobacillus Drugs 0.000 title description 2
- 238000000855 fermentation Methods 0.000 claims abstract description 78
- 230000004151 fermentation Effects 0.000 claims abstract description 78
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 60
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims abstract description 52
- 241001400472 Omiza Species 0.000 claims abstract description 15
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 62
- 239000012138 yeast extract Substances 0.000 claims description 62
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 44
- 238000010790 dilution Methods 0.000 claims description 10
- 239000012895 dilution Substances 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 239000007858 starting material Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 68
- 239000004310 lactic acid Substances 0.000 abstract description 35
- 235000014655 lactic acid Nutrition 0.000 abstract description 34
- 241000894006 Bacteria Species 0.000 abstract description 13
- 235000000346 sugar Nutrition 0.000 abstract description 12
- 235000013399 edible fruits Nutrition 0.000 abstract description 10
- 235000013361 beverage Nutrition 0.000 abstract description 8
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical group [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 41
- 239000004223 monosodium glutamate Substances 0.000 description 41
- 230000003247 decreasing effect Effects 0.000 description 17
- 230000008859 change Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 210000004556 brain Anatomy 0.000 description 7
- 239000000284 extract Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 3
- 241000235346 Schizosaccharomyces Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000016127 added sugars Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- NFMLWRCAFGMYPI-UHFFFAOYSA-N butanedioic acid;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.OC(=O)CCC(O)=O NFMLWRCAFGMYPI-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 201000002676 cerebral atherosclerosis Diseases 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/40—Fermented products; Products treated with microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/218—Yeast extracts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA) 생산 젖산균을 이용한 오미자 발효음료 제조방법에 관한 것으로, 더욱 상세하게는 GABA를 생산하는 젖산균인 락토바실러스 플란타럼(Lactobacillus plantarum) EJ2014(KCCM11545P)를 이용하여 고농도 GABA가 함유된 오미자 발효 음료 제조방법에 관한 것이다. 본 발명은 오미자 열매 및 GABA 생성 젖산균을 이용한 GABA가 증진된 오미자 젖산 발효물 제조방법을 제공한다. 단기간에 젖산발효에 의한 GABA강화 오미자 발효액은 경제적, 영양 및 기능적인 면에서 우수한 발효 제품으로 사료된다. 또한 이런 발효기술은 기존의 당절임에 의한 효소식품의 제조방법을 개선할 수 있는 발효방법으로 응용가치가 높다고 판단된다. The present invention relates to a process for producing fermented Omija beverage using lactic acid bacteria producing gamma-aminobutyric acid (GABA). More particularly, the present invention relates to a method for producing fermented Omija beverage using Lactobacillus plantarum plantarum ) EJ2014 (KCCM11545P). The present invention relates to a method for producing fermented Omija beverage containing high-concentration GABA. The present invention provides a method for producing GABA-enhanced Omija lactic acid fermentation product using Omiza fruit and GABA-producing lactic acid bacteria. The fermentation of GABA-enhanced Schizandra chinensis by lactic acid fermentation in a short period of time is considered to be an excellent fermentation product in terms of economic, nutritional and functional properties. This fermentation technology is considered as a fermentation method that can improve the manufacturing method of enzyme food by conventional sugar - picking.
Description
본 발명은 GABA 생산 젖산균을 이용한 오미자 발효음료 제조방법에 관한 것으로, 더욱 상세하게는 GABA를 생산하는 젖산균인 락토바실러스 플란타럼(Lactobacillus plantarum) EJ2014(KCCM11545P)를 이용하여 고농도 GABA가 함유된 오미자 발효 음료 제조방법에 대한 것이다.The present invention relates to a method for producing a fermented drink of Omija using GABA-producing lactic acid bacteria, and more particularly to a method for producing GABA fermented beverage by using Lactobacillus plantarum plantarum ) EJ2014 (KCCM11545P). The present invention relates to a method for producing fermented Omija beverage containing high concentration GABA.
자연계에 존재하는 식물 중에 질병의 방지와 노화 억제 등 생체조절기능을 가지는 기능성 성분들이 다량 함유되어 있다는 것이 밝혀져 천연식품소재에 관한 연구가 활발히 이루어지고 있다.It has been found that plants present in the natural environment contain a large amount of functional components having biological control functions such as prevention of disease and suppression of aging, and studies on natural food materials have been actively conducted.
오미자(Schisandra chinensis)는 목련과에 속하는 상록성 덩굴식물로 품종, 숙도 및 재배환경의 차이에 따라 다소 차이가 있지만 단맛, 신맛, 쓴맛, 매운맛 및 짠맛 등이 어우러진 독특한 풍미를 나타낼 뿐만 아니라, 안토시아닌에 의해 선명한 붉은색을 나타내는 것이 특징이다. 오미자에는 탄수화물, 조단백질과 조지방, K, Mn 및 Ca 등이 많이 함유되어 있으며, 특히 열매는 알코올 해독작용 및 항산화 작용이 뛰어난 것으로 보고되어 있다. 이러한 오미자는 안토시아닌 뿐만 아니라 플라보노이드 및 유기산류 등이 풍부하여, 예로부터 한방에서는 거담, 자양, 간장제 등으로 이용되었다. 또한 오미자는 중추억제 작용, 혈압강하 작용 및 알코올 해독작용이 있는 것으로 알려져 있는 생약재로서 암 예방, 노화억제 및 면역조절작용 등 다양한 생리적 기능성이 보고되고 있다. 한편 오미자 추출물의 붉은 색은 anthocyanin에 기인하며 차, 술 등의 가공제품에 천연의 붉은 색을 부여한다. Schisandra chinensis ) is an evergreen vine plant belonging to the Magnoliaceae family. It has a distinctive flavor that is a mixture of sweetness, sourness, bitter taste, spicy taste and salty taste, but also a bright red color by anthocyanin . Carbohydrates, crude protein, crude fat, K, Mn, and Ca are abundant in Omija, and fruits are reported to have excellent alcohol detoxification and antioxidant activity. Such Omiza is rich in anthocyanins as well as flavonoids and organic acids, and has been used as a genome, a nourishing agent, a soy sauce, and the like in herbal compositions since ancient times. In addition, Omija is a herbal medicine known to have central inhibitory action, hypotensive action and alcohol detoxifying action, and various physiological functions such as cancer prevention, aging suppression and immunoregulatory action have been reported. On the other hand, the red color of Omiza extract is attributed to anthocyanin and imparts a natural red color to processed products such as tea and liquor.
최근 세계 음료시장에서는 건강 기능성을 지닌 추출물을 이용한 음료가 차지하는 비중이 점차 커지는 추세이며 위와 같은 특징으로 인하여 오미자는 상품성 높은 원료로서 새롭게 주목받고 있다.
In the recent global beverage market, beverages account for an increasing proportion of beverages using health functional extracts. Due to these characteristics, omija has attracted attention as a high-commodity raw material.
감마 아미노부티르산(gama amino butyric acid; GABA)은 4-아미노부틸산으로써 L-글루타메이트(L-glutamate) 기질이 탈탄산 반응에 의해 생성되며, 이에 관여하는 효소로는 글루타메이트 디카르복실라제(glutamate decarboxylase; GAD)가 있으며 피리독시드-5'-포스페이트(pyridoxid-5'-phosphate) 의존성 경로로 합성된다. GABA는 단백질에서는 발견이 되지 않는 비단백질성 아미노산으로 뇌나 척수에 존재하는 신경전달물질로 혈류를 개선하며 뇌의 산소공급을 증가시켜 뇌의 대사촉진 및 뇌 기억을 증진시키는 뇌의 영양제로 알려져 있다. GABA는 글루타메이트(glutamate)가 신경을 활성화시키는 것과는 달리 신경활성을 억제하는 것으로 알려져 있으며, 이러한 기능은 신경세포의 기능과 정보처리에 지대한 영향을 미치게 되는데 특히 감각 뇌에서 방향 민감성, 각도 민감성 반응 등을 결정하며 정교한 운동기능도 조율하는 것으로 알려져 있다. GABA의 뇌혈류 촉진 효과와 산소공급 증가효과는 뇌세포의 대사를 촉진시킴으로써 뇌졸중의 후유증 및 뇌동맥경화증 등에 개선효과가 나타나 의약품으로 사용되고 있다. GABA의 기능성이 알려지면서 의약품으로서 뿐만 아니라 기능성 식품소재로 이용하고자 하는 연구가 많이 시도되고 있으며, 이들 연구들은 현미, 녹차, 맥아, 배추 등에 자연적으로 약간 함유되어 있는 GABA의 함량을 증대시키는 데 집중되어 있다. 그러나 자연계의 식물을 원재료로 한 GABA의 생산에는 한계가 있으므로 대량 생산하기 위해서는 미생물을 이용한 연구가 필요한 실정이다.Gamma amino butyric acid (GABA) is a 4-aminobutyric acid, which is produced by a decarboxylation reaction of L-glutamate substrate. Glutamate decarboxylase (glutamate decarboxylase) ; GAD) and is synthesized as a pyridoxid-5'-phosphate dependent pathway. GABA is a nonprotein amino acid that is not found in proteins. It is a neurotransmitter in the brain or spinal cord. It is known as a brain nutrient that promotes blood flow through the brain and promotes brain metabolism and brain memory by increasing oxygen supply to the brain. GABA is known to inhibit neuronal activity as opposed to glutamate activating neurons, and this function has a profound effect on the function and information processing of neurons, especially in sensory brains such as direction sensitivity, angle sensitivity It is also known to coordinate and elaborate exercise functions. GABA stimulates the cerebral blood flow and increases oxygen supply, promotes the metabolism of brain cells, so that the after effects of stroke and cerebral atherosclerosis is improving and is being used as a medicine. As the function of GABA is known, many studies have been made to use it as a functional food material as well as pharmaceuticals. These studies have focused on increasing the content of GABA, which is naturally contained in brown rice, green tea, malt and cabbage have. However, since there is a limit to the production of GABA using natural plant materials, studies using microorganisms are required for mass production.
본 발명의 목적은 오미자 열매 및 GABA 생성 젖산균을 이용한 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 오미자 젖산 발효물 제조방법을 제공하는데 있다. It is an object of the present invention to provide a method for producing an omega-lactic acid fermented product in which gamma-aminobutyric acid (GABA) is enhanced by using Omiza fruit and GABA-producing lactic acid bacteria.
상기 목적을 달성하기 위하여, 본 발명은 (1) 오미자를 착즙하고 물로 희석하여 오미자 희석액을 제조하는 단계; (2) 상기 오미자 희석액 전체 100 중량부에 대해 모노소듐 글루타메이트(mono sodium glutamate; MSG) 1 내지 5 중량부 및 효모 추출물(yeast extract) 0.1 내지 1 중량부를 첨가하여 혼합하는 단계; (3) 상기 혼합물에 젖산균 스타터(starter)를 접종하고 배양하여 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 오미자 젖산 발효물 제조방법을 제공한다.In order to achieve the above object, the present invention provides a method for preparing an Omija diluted solution, comprising the steps of: (1) preparing an Omija diluted solution by sifting and diluting Omija; (2) adding 1 to 5 parts by weight of monosodium glutamate (MSG) and 0.1 to 1 part by weight of yeast extract to 100 parts by weight of the total of the omiza diluted solution; (3) a step of inoculating a lactic acid bacteria starter into the mixture, followed by culturing and fermenting the same, wherein the gamma-aminobutyric acid (GABA) is promoted.
또한, 본 발명은 상기의 방법에 의해 제조된 오미자 젖산 발효물을 포함하는 GABA 증진 오미자 발효음료를 제공한다.The present invention also provides a GABA-enhanced Omija fermented beverage comprising the fermented product of Omija lactic acid produced by the above method.
본 발명은 GABA 생산 젖산균을 이용한 오미자 발효음료 제조방법에 관한 것으로서, 약리효과가 우수한 오미자 열매에 젖산균을 이용한 젖산발효를 통하여 GABA가 함유되어 있는 기능성 식품개발을 목표로 수행하였으며, 오미자 열매의 고유의 색, 맛과 향을 그대로 살리면서 기능성 물질인 GABA가 증진된 젖산균이 함유된 기능성 발효제품을 개발하고자 하였다. The present invention relates to a method for producing fermented Omija beverage using lactic acid bacteria producing GABA, and aims at the development of a functional food containing GABA by lactic acid fermentation using a lactic acid bacterium for the fruit having excellent pharmacological effect. We tried to develop a functional fermented product containing lactic acid bacteria enhanced functional substance GABA while preserving color, taste and aroma.
도 1은 희석 배수에 따른 오미자 젖산 발효액의 pH, 산도 변화를 나타낸다.
도 2는 희석 배수에 따른 오미자 젖산 발효액의 GABA 함량변화를 나타낸다.
도 3은 열처리를 하지 않은 오미자 젖산 발효액의 pH, 산도 변화를 나타낸다.
도 4는 효모 추출물(Yeast extract; YE*) 농도에 따른 오미자 젖산 발효액의 pH, 산도 변화를 나타낸다.
도 5는 효모 추출물(Yeast extract; YE) 농도에 따른 오미자 젖산 발효액의 GABA 함량 변화를 나타낸다.
도 6은 효모 추출물(Yeast extract; YE) 농도에 따른 오미자 젖산 발효액의 색 변화를 나타낸다(A: YE 0%, B: YE 0.25%, C: YE 0.5%, D: YE 1%).
도 7은 여과 오미자 발효액의 pH, 산도 변화를 나타낸다.
도 8은 여과 오미자 발효액의 GABA 함량 변화를 나타낸다(M+Y= MSG 2%, YE 0.5%).
도 9는 여과 오미자 발효액의 색 변화를 나타낸다(A: 대조군, B: M+Y).
도 10은 MSG와 YE 첨가에 따른 오미자 젖산 발효 과정을 나타낸다.
도 11은 MSG와 YE 첨가 조건에 따른 오미자 발효액의 pH, 산도 변화를 나타낸다.
도 12는 MSG와 YE 첨가 조건에 따른 오미자 발효액의 GABA 함량 변화를 나타낸다(M+Y= MSG 2%, YE 0.5%).
도 13은 MSG와 YE를 첨가한 오미자 발효액의 발효시간에 따른 색 변화를 나타낸다(A1): MSG 0%, YE 0%, B2): MSG 2%, C3 ): YE 0.5%, D4 ): MSG 2%, YE 0.5%).
도 14는 오미자발효액에 오미자 추출액을 단계적으로 혼합한 후 최종 제품의 성상을 나타낸다.FIG. 1 shows the pH and acidity of the fermentation broth of Schizosaccharomyces lactis according to the dilution factor.
FIG. 2 shows changes in the content of GABA in the fermentation broth of Omija lactic acid according to the dilution ratio.
Fig. 3 shows changes in pH and acidity of the fermentation broth of Omija lactic acid without heat treatment.
FIG. 4 shows changes in pH and acidity of the lactic acid fermentation solution according to yeast extract (YE *) concentration.
FIG. 5 shows changes in the content of GABA in the fermentation broth of Omija lactic acid according to yeast extract (YE) concentration.
FIG. 6 shows the color change of the fermentation broth of Omija lactic acid according to yeast extract (YE) concentration (A:
Fig. 7 shows changes in pH and acidity of the filtered Schizosaccharomyces cerevisiae.
Fig. 8 shows the change in the GABA content of the filtrated Schizandra chinensis (M + Y =
Fig. 9 shows the color change of the filtered Schizosaccharum fermentation broth (A: control group, B: M + Y).
Fig. 10 shows the process of fermentation of omiga lactic acid by addition of MSG and YE.
Fig. 11 shows pH and acidity changes of the Schizandra chinensis solution according to MSG and YE addition conditions.
Fig. 12 shows changes in the GABA content of the Schizosaccharomyces cerevisiae according to MSG and YE addition conditions (M + Y =
13 shows the color change of the fermentation broth of MSM and YE added with fermentation time according to the fermentation time (A 1) :
Fig. 14 shows the characteristics of the final product after stepwise mixing the Omija extract with the fermentation broth of Omija.
본 발명은 (1) 오미자를 착즙하고 물로 희석하여 오미자 희석액을 제조하는 단계; (2) 상기 오미자 희석액 전체 100 중량부에 대해 모노소듐 글루타메이트(mono sodium glutamate; MSG) 1 내지 5 중량부 및 효모 추출물(yeast extract) 0.1 내지 1 중량부를 첨가하여 혼합하는 단계; (3) 상기 혼합물에 젖산균 스타터(starter)를 접종하고 배양하여 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 오미자 젖산 발효물 제조방법을 제공한다. The present invention relates to (1) a step of preparing an Omija diluted solution by juicing and diluting Omija; (2) adding 1 to 5 parts by weight of monosodium glutamate (MSG) and 0.1 to 1 part by weight of yeast extract to 100 parts by weight of the total of the omiza diluted solution; (3) a step of inoculating a lactic acid bacteria starter into the mixture, followed by culturing and fermenting the same, wherein the gamma-aminobutyric acid (GABA) is promoted.
바람직하게는, 상기 (1)단계의 산수유 희석액은 희석배수가 1 내지 5배일 수 있으나, 이에 제한되는 것은 아니다.
Preferably, the dilution ratio of the diluted crude acidic milk of step (1) may be 1 to 5 times, but is not limited thereto.
상세하게는 상기 젖산균은 락토바실러스 플랜타럼(Lactobacillus plantarum) 균주인 것을 특징으로 한다. 본 발명의 실시예에서 사용된 락토바실러스 플랜타럼(Lactobacillus plantarum) 균주는 EJ2014 (KCCM11545P)이다.Specifically, the lactic acid bacteria is Lactobacillus plan tareom (Lactobacillus plantarum ). The Lactobacillus plantarum used in the examples of the present invention plantarum ) strain EJ2014 (KCCM11545P).
상세하게는, 상기 (3) 단계의 발효는 25 내지 30℃에서, 1 내지 120시간 동안 발효할 수 있으나, 이에 제한되는 것은 아니다.
In detail, the fermentation in the step (3) may be performed at 25 to 30 DEG C for 1 to 120 hours, but is not limited thereto.
본 발명에 있어서, "스타터(starter)"란 발효물을 제조하는 경우에 사용하는 미생물 배양액을 말한다. 따라서 스타터 미생물의 종류는 그 제품의 특성을 결정하게 되며 제품의 품질에 중요한 영향을 미친다. 미생물 중에서 스타터로 사용되고 있는 것은 박테리아, 곰팡이, 효모 등을 들 수 있으며, 이것을 단독 혹은 혼합하여 사용할 수 있다.
In the present invention, the term "starter" refers to a culture medium of microorganisms used for producing a fermented product. Therefore, the types of starter microorganisms determine the characteristics of the product and have an important influence on the quality of the product. Bacteria, fungi, yeast, etc., which are used as starters in microorganisms, can be used alone or in combination.
또한, 본 발명은 상기의 방법에 의해 제조된 오미자 젖산 발효물을 포함하는 GABA 증진 오미자 발효음료를 제공한다. The present invention also provides a GABA-enhanced Omija fermented beverage comprising the fermented product of Omija lactic acid produced by the above method.
상기 오미자 발효음료는 상기 오미자 젖산 발효물 및 오미자 원액을 1-100:1로 혼합하여 제조할 수 있으나, 이에 제한되는 것은 아니다.
The Omija fermented beverage can be prepared by mixing the Omija lactic acid fermented product and the raw stock solution of Omija at a ratio of 1-100: 1, but is not limited thereto.
이하, 하기 실시예를 통해 본 발명을 보다 상세하게 설명한다. 다만, 이러한 실시예에 의해 본 발명이 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the present invention is not limited by these examples.
< < 실시예Example 1 > 희석배수에 따른 오미자 젖산 발효 1> Fermentation of Omija lactic acid according to dilution factor
오미자 열매를 선별하여 파쇄한 후 MSG를 2%, 수크로즈(sucrose)를 5%, 효모추출물(yeast extract)을 0.5% 첨가한 후, 증류수를 이용하여 2배, 3배, 4배 희석하였으며 80℃에서 30분간 열처리하였다. 젖산균 락토바실러스 플란타럼(Lactobacillus plantarum) EJ2014 균을 MRS broth에서 1일 동안 배양한 스타터(starter)를 1% 첨가하여 3일 동안 발효 분석하였다. 오미자 발효액의 생균수 변화에 대한 결과는 표 1과 같다. 2배 희석한 오미자액에서는 3일째 5.5×107 CFU/mL, 4배 희석한 오미자는 1.2×109 CFU/mL로 나타나 균 생육을 위해서 오미자를 4배 희석하는 조건이 적합할 것으로 사료된다. 또한 발효물의 pH와 산도는 희석을 할수록 pH가 증가하고 산도가 감소하는 경향을 보였다(도 1). 4배 희석한 발효액에서 발효가 진행될수록 pH가 3.75에서 1일째 4.01로 증가하였다가 3일째 3.54까지 감소하는 것을 알 수 있었고, 산도는 발효 전 1.91%에서 3일째까지 계속 증가하여 3일째에 2.81%가 되는 것을 알 수 있었다. 오미자 발효물의 GABA 함량을 측정하기 위한 TLC 분석을 이용하였을 때, GABA 함량은 오미자의 희석배수에 따라 차이가 없는 것으로 보인다(도 2).
After isolating and isolating Schizandra chinensis, MSG was added 2%,
< < 실시예Example 2 > 열처리를 하지 않은 오미자 열매의 젖산발효 2> Lactic acid fermentation of the untreated fruit of Omiza
<실시예 1>의 결과를 바탕으로, 같은 조건에서 오미자 열매를 4배 희석하여 열처리를 하지 않았을 때 생균수와 당도의 변화를 표 2에 나타냈다. 생균수는 3일째에 2.1×109 CFU/mL로 열처리를 하였을 때보다 전반적으로 더 높게 나타났다. pH는 발효 전에 4.26에서 3일째 3.59로 감소하였으며 산도는 1.8%에서 3일째 3.8%까지 증가한 것을 알 수 있었다(도 3). 이는 발효하기 전 당도가 9.40 °Brix에서 3일째 8.53 °Brix까지 감소한 것으로 보아 첨가한 설탕을 영양원으로 이용한 것으로 보이며, GABA생산에는 영향을 미치지 않는 것으로 보인다.
Based on the results of <Example 1>, the change in the number of viable cells and the change in sugar content when the omza fruit was diluted 4 times with no heat treatment under the same conditions are shown in Table 2. The number of viable cells was generally higher on the 3rd day than on the heat treatment of 2.1 × 10 9 CFU / mL. The pH decreased from 4.26 to 3.59 at 3 days before fermentation, and the acidity increased from 1.8% to 3.8% at 3 days (Fig. 3). This suggests that the sugar content decreased from 9.40 ° Brix to 8.53 ° Brix on the third day before fermentation, so it seems to use the added sugar as a nutrient and does not seem to affect GABA production.
(°Brix)Soluble solid
(° Brix)
< < 실시예Example 3 > 설탕을 3> Sugar 첨가 하지Do not add 않은 오미자 열매의 효모 추출물( Yeast extract of non-Omiza fruit yeastyeast extract) 농도에 따른 젖산발효 Extraction of Lactic Acid
설탕을 첨가하지 않은 조건에서 효모 추출물(yeast extract; YE)의 농도를 달리하여 발효하여 보았을 때, 표 3에서 보는 것과 같이 생균수는 YE 0.25% 이상 첨가한 모든 조건에서 1일째부터 109 CFU/mL로 증가하여 3일째까지 유지되었다. pH는 0%에서 4.14에서 3일째에 3.93으로 감소하였고, 1% 첨가한 조건에서는 4.13에서 4.30으로 약간 증가하였다(도 4). 당도는 YE 0.5%첨가한 조건이 6.20 °Brix에서 5.17 °Brix로 약 1.03 °Brix정도 감소하였고, YE 1% 첨가한 조건에서는 6.53 °Brix에서 5.77 °Brix로 0.76 °Brix 감소하였다. 도 5에서 나타낸 바와 같이, GABA 함량이 효모 추출물(yeast extract) 농도 의존적으로 증가함을 알 수 있으며, 0.5% 첨가한 조건에서는 3일째에 약 0.25% GABA, 1% 첨가한 조건에서는 0.25% 이상의 GABA가 생산되었다. 그러나 오미자 발효액에는 GABA로 전환되지 않고 남아있는 MSG의 잔존율이 높았다. 색도를 측정 해 보았을 때, L값은 4가지 조건에서 발효시간이 지남에 따라 비슷한 수치로 감소하였으며, a값은 효모 추출물(yeast extract) 농도가 증가할수록 발효시간이 지남에 따라 농도 의존적으로 감소하였다(표 4). b값 또한 발효시간이 지남에 따라 YE 농도 의존적으로 감소하는 것으로 나타났다(표 4). 발효시간에 따른 색의 변화를 나타낸 도 6을 살펴보면, YE 농도가 진할수록 오미자 본래의 색을 잃고 발효가 진행됨에 따라 황색이 진해지고 붉은 색이 빠짐을 보였다.
As shown in Table 3, when the yeast extract (YE) concentration was changed under the condition that no sugar was added, the viable cell counts were 10 9 CFU / mL and maintained until the third day. The pH decreased from 4.14 at 0% to 3.93 at 3 days and slightly increased from 4.13 to 4.30 at 1% addition (Fig. 4). The sugar content decreased by about 1.03 ° Brix from the addition of 0.5% YE to 5.17 ° Brix at 6.20 ° Brix and decreased by 0.76 ° Brix from 6.53 ° Brix to 5.77 ° Brix under the condition of adding 1% YE. As shown in FIG. 5, the GABA content was found to increase in a yeast extract concentration-dependent manner. In the case of 0.5% addition, about 0.25% GABA was added on the third day and 0.25% Was produced. However, the survival rate of MSG remaining in Omija fermentation broth was not converted to GABA. L value was decreased to similar value with fermentation time under 4 conditions. The value of a decreased with increasing yeast extract concentration in concentration - dependent manner (Table 4). b values also decreased with fermentation time depending on YE concentration (Table 4). 6 showing changes in color depending on the fermentation time. As the YE concentration was increased, the original color of the omija was lost and the yellow color became darker and the red color appeared to be lost as the fermentation progressed.
concentration(%)YE
concentration (%)
concentration(%)YE
concentration (%)
valueColor
value
L1 ): 밝기(Lightness), a2 ): 적색도(redness), b3 ) 황색도(yellowness)
L 1 ) : Lightness, a 2 ) : redness, b 3 ) yellowness
< < 실시예Example 4 > 4> GABAGABA 생산 최적화를 위한 여과 Filtration for production optimization
GABA 함량을 더 높이기 위하여 오미자를 파쇄하지 않고 씨를 제외한 열매만을 이용하여 으깬 후 끓인 증류수로 희석하였으며, 발효 한 후에 즙만 채취하였다. YE 0.5%, MSG 2%를 첨가하고 3일간 발효하였을 때, 생균수는 대조군(control)에서 1일째 108로 증가하여 3일까지 유지되었으며, GABA 생산 조건인 MSG, YE 첨가 조건에서는 1일째부터 109로 증가하여 3일째까지 유지되는 것을 볼 수 있다(표 5). 도 7은 pH와 산도의 변화를 나타낸 것이며, 대조군(control)에서 3.23에서 3.29로 증가하고 산도는 1.58%에서 1.48%로 감소하여 전체적으로 변화가 없었다. 반면 MSG, YE 첨가하여 젖산 발효한 조건에서는 pH가 4.21에서 4.92로 증가하였으며 산도는 1.65%에서 0.87%로 감소하는 것을 볼 수 있었다. GABA 함량을 측정하였을 때, 대조군(control)에서는 GABA가 전혀 없는 것을 알 수 있으며, MSG, YE 첨가 조건에서는 발효 2일째에 GABA standard 0.5%와 비슷한 크기로 증가하였고, 3일째는 약 1%까지 증가한 것으로 나타났다(도 8). 도 9에서 보는 것과 같이, 대조군(control)에서는 색이 변하지 않고 젖산발효가 되면서 pH 값의 증가에 따라 색이 황색으로 변하는 것을 알 수 있었다.
In order to increase the GABA content, the omelet was crushed without using crushed seeds except for the seeds, and then diluted with boiled distilled water. After the fermentation, only juice was collected. When 0.5% YE and 2% MSG were added and fermented for 3 days, the number of viable cells increased to 10 8 on
Control: MSG, 효모 추출물(yeast extract) 0%, M+Y: MSG 2%, 효모추출물(yeast extract) 0.5%
Control: MSG,
< < 실시예Example 5 > 5> MSGMSG 와 Wow YEYE 첨가에 따른 오미자 젖산 발효 Lactic Acid Fermentation by Addition of Omija
MSG와 YE 첨가에 따른 오미자 젖산 발효를 수행하였다(도 10). 오미자 발효 후 MSG와 YE 첨가에 따른 오미자 발효액의 색 변화를 실험하였다. 이전의 조건과 동일하게 씨를 제외한 오미자 열매만을 이용하여 으깨서 끓는 증류수로 희석하였으며, 발효 후에 즙만을 채취하였다. 생균수는 발효 전 3.0Ⅹ107 CFU/mL에서 질소원이 첨가된 조건에서 모두 생균수가 발효 3일까지 108 CFU/mL이상 증가하는 것으로 나타났다. MSG와 YE를 함께 사용한 조건에서 발효 3일째 1.4Ⅹ109 CFU/mL로 생균수가 가장 높게 나타났다(표 6). YE 첨가가 미생물 증식 및 영양원으로 좋은 것을 알 수 있었다. 당도를 나타낸 표 7에 나타낸 바와 같이, 대조군(control)과 MSG 첨가조건에서는 1.2 °Brix 정도로 감소하였고, YE를 첨가한 조건과, MSG와 YE를 함께 첨가한 조건에서는 1.7 °Brix로 감소하였다. pH와 산도를 측정하였을 때(도 11), 발효 전 MSG만 첨가하여도 pH가 3.14에서 4.16으로 증가하는 것을 볼 수 있으며, 이에 도 13에서 보는 것과 같이 MSG 첨가하였더니 바로 붉은 색이 빠졌고, YE의 첨가는 큰 영향을 주지 않는 것으로 보인다. 이는 MSG를 첨가함으로써 pH값이 상승하면서 색에 영향을 주는 것으로 생각된다. 발효가 진행됨에 따라 대조군(control)의 pH는 3.14에서 3.30까지 증가하고 산도는 1.94%에서 1.19%까지 감소하는 것을 볼 수 있다. GABA 생산조건인 MSG와 YE를 함께 첨가하였을 때는 pH가 4.19에서 5.03으로 가장 많이 증가하였고, 산도는 1.74%에서 3일까지 0.56%로 변화가 가장 많은 것으로 나타났다.The addition of MSG and YE resulted in the fermentation of succinic acid lactic acid (Fig. 10). After the addition of MSG and YE after the fermentation of Omija, the color change of the fermentation broth of Omija was examined. The same conditions as the previous one were used to dilute only boiled distilled water using only Omiza fruit except for seeds, and only juice was collected after fermentation. The number of viable cell counts increased by more than 10 8 CFU / mL before fermentation at 3.0 × 10 7 CFU / mL before addition of nitrogen source. On the third day of fermentation under conditions using MSG and YE, the number of viable cells was the highest at 1.4 × 10 9 CFU / mL (Table 6). YE addition was good for microbial growth and nutrition. As shown in Table 7 showing the sugar content, it decreased to 1.2 ° Brix in the case of control and MSG addition, and decreased to 1.7 ° Brix in the case of addition of YE and MSG and YE together. When pH and acidity were measured (FIG. 11), the pH increased from 3.14 to 4.16 even after addition of MSG before fermentation. As shown in FIG. 13, when MSG was added, red color disappeared and YE Is not likely to have a significant effect. It is thought that the addition of MSG increases the pH value and affects the color. As the fermentation progresses, the pH of the control increases from 3.14 to 3.30 and the acidity decreases from 1.94% to 1.19%. When MSG and YE were added together, the pH increased from 4.19 to 5.03, and acidity changed from 1.74% to 3 days to 0.56%.
색의 변화를 관찰한 도 13에서 YE를 첨가한 조건에서는 붉은 색을 유지하고 있었으며 발효 3일째 되는 날 황색도가 증가하는 것을 알 수 있다. GABA 생산 조건인 MSG와 YE함께 첨가한 조건에서는 1일째부터 붉은 색이 빠지며 황색으로 보인다. 색도를 측정하였을 때, 대조군(control)은 3일째까지 큰 변화가 없었으며, MSG 첨가한 조건에서는 발효가 진행됨에 따라 a값이 18.24에서 8.61로 많이 감소하는 것을 알 수 있고, b값 또한 6.15에서 4.04로 감소함을 알 수 있었으며, MSG와 YE함께 첨가한 조건에서도 a값이 15.74에서 5.39로 감소하고, b값은 7.85에서 6.28로 감소하는 것을 알 수 있다(표 8). GABA 함량을 측정하였을 때, 대조군(control)과 MSG만 첨가한 조건에서는 MSG가 GABA로 전환이 전혀 이루어지지 않았으며, YE만을 첨가한 조건에서는 GABA가 미량 전환되는 것을 알 수 있었다. MSG, YE를 함께 첨가한 조건에서는 1일째부터 MSG를 소진하면서 GABA로 전환되는 것을 볼 수 있고, 3일째에는 MSG 2%를 거의 소진하고 GABA standard 1%와 비슷한 농도로 전환되었음을 알 수 있다(도 12). 이것을 유리 아미노산 정량 분석을 했을 때, 글루탐산(glutamic acid)이 발효 전 1.4%에서 발효 후 0.4%로 줄어든 것을 알 수 있으며, GABA가 0.02%에서 0.92로 약 1% 증가한 것을 알 수 있다(표 9).
In FIG. 13, when the change of color was observed, it was found that red color was maintained under the condition of adding YE, and that yellowness increased on the third day of fermentation. GABA production conditions, MSG and YE, were added together and the red color appeared to be yellow from
L1 ): 밝기(Lightness), a2 ): 적색도(redness), b3 ) 황색도(yellowness), M+Y4): MSG 2%, YE 0.5%
L 1 ) : Lightness, a 2 ) : redness, b 3 ) yellowness, M + Y 4) :
< < 실시예Example 6 > 오미자 젖산 발효액의 시제품 6> Prototype of Omija lactate fermentation broth
젖산발효 후에 GABA 물질이 강화된 오미자발효액의 색상은 발효액의 pH상승에 따라 퇴색되는 경향을 보였다. 따라서, 오미자발효액에 오미자추출액을 일정 비율로 혼합한 후 최종 오미자 발효액의 시제품을 완성하였다. 오미자 추출액이 25 또는 50% 수준으로 첨가되었을 때 적색의 고유한 오미자 색상을 얻을 수 있었다. 도 14는 오미자발효액에 오미자 추출액을 단계적으로 혼합한 후 최종 제품의 성상을 나타내고 있다. 따라서 오미자 열매를 이용하여 유용 젖산균의 발효조건을 최적화함으로써 단기간에 오미자 열매의 젖산발효를 통해서 기능성 물질인 GABA가 다량 함유되고 젖산균 probiotic가 7 x 108 정도를 포함하는 오미자 발효제품을 완성하였다. After fermentation of lactic acid, the color of GABA - enriched Omija fermentation broth tended to be discolored due to the increase of pH of fermentation broth. Therefore, a prototype of the final Omija fermentation broth was completed after mixing the Omija broth with a certain proportion of the Omija broth. When Omiza extract was added at the level of 25 or 50%, a unique red Omiza color could be obtained. Fig. 14 shows the characteristics of the final product after stepwise mixing the Omija extract with the fermentation broth of Omija. Thus, by optimizing the fermentation conditions of useful lactic acid bacteria using Omiza berries, we completed the Omija fermentation product containing lactic acid bacterium probiotic of about 7 × 10 8 in a short period of time by lactic acid fermentation of the fruit of Omiza fruit containing a large amount of functional substance GABA.
이는 일반적인 당절임에 의해서 6개월 이상 장기발효 숙성과정을 거치면서 얻어지는 오미자발효액이 고농도의 당 농도에 때문에 소비자들이 섭취를 기피하는 경향이 있으며, 장기간 발효에 따른 비경제적인 면을 고려할 때 본 발명에서 단기간에 젖산발효에 의한 GABA강화 오미자 발효액은 경제적, 영양 및 기능적인 면에서 우수한 발효 제품으로 사료된다. 또한 이런 발효기술은 기존의 당절임에 의한 효소식품의 제조방법을 개선할 수 있는 발효방법으로 응용가치가 높다고 판단된다. This is because, in general, the fermented milk of Omija obtained through a long-term fermentation aging process for 6 months or more by general sugar picking tends to avoid consumption by consumers at a high concentration of sugar, and in view of the non- Fermented LAB fermented by lactic acid fermentation is considered to be an excellent fermentation product in terms of economic, nutritional and functional properties. This fermentation technology is considered as a fermentation method that can improve the manufacturing method of enzyme food by conventional sugar - picking.
Claims (5)
(2) 상기 오미자 희석액 전체 100 중량부에 대해 모노소듐 글루타메이트(mono sodium glutamate; MSG) 1 내지 5 중량부 및 효모 추출물(yeast extract) 0.1 내지 1 중량부를 첨가하여 혼합하는 단계;
(3) 상기 혼합물에 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA) 생산능을 가진 락토바실러스 플랜타럼(Lactobacillus plantarum) EJ2014 (KCCM11545P) 균주 스타터(starter)를 접종하고 배양하여 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 오미자 젖산 발효물 제조방법. (1) preparing omiza diluted solution by juicing and diluting omija;
(2) adding 1 to 5 parts by weight of monosodium glutamate (MSG) and 0.1 to 1 part by weight of yeast extract to 100 parts by weight of the total of the omiza diluted solution;
(3) Inoculating the above mixture with a starter of Lactobacillus plantarum EJ2014 (KCCM11545P) having the ability to produce gamma-aminobutyric acid (GABA), culturing and fermenting Wherein the gamma-aminobutyric acid (GABA) is promoted in the presence of a reducing agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140074824A KR101616187B1 (en) | 2014-06-19 | 2014-06-19 | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140074824A KR101616187B1 (en) | 2014-06-19 | 2014-06-19 | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150145764A KR20150145764A (en) | 2015-12-31 |
KR101616187B1 true KR101616187B1 (en) | 2016-04-29 |
Family
ID=55128558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140074824A KR101616187B1 (en) | 2014-06-19 | 2014-06-19 | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101616187B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220010805A (en) | 2020-07-20 | 2022-01-27 | 농업회사법인 주식회사 아람바이오 | Method of manufacturing fermented beverage and distilled liquor |
KR20220133520A (en) | 2021-03-25 | 2022-10-05 | 계명대학교 산학협력단 | A novel Lactobacillus plantarum KS2020 strain having GABA production activity, and method for preparing red ginseng fermented product or lacquer tree fermented product containing high concentration γ-PGA and GABA using the strain |
KR102578454B1 (en) | 2022-07-15 | 2023-09-21 | 양일호 | Method for manufacturing black pine leaf fermented beverage using black omija fermented liquid and fermented black pine leaf fermented beverage produced thereby |
KR102668792B1 (en) * | 2023-01-03 | 2024-05-29 | 한국화학연구원 | Health functional food and pharmaceutical composition to help improve sleep quality |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115322940B (en) * | 2022-10-13 | 2023-02-03 | 哈尔滨美华生物技术股份有限公司 | Lactobacillus plantarum and sleep-aiding and anti-depression product and application thereof |
CN115968988A (en) * | 2022-12-20 | 2023-04-18 | 合肥中科健康生物产业技术研究院有限公司 | Fermented litchi juice with antioxidant activity and preparation method and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130050512A (en) * | 2011-11-08 | 2013-05-16 | 정세영 | Manufacture of omija fermented beverage increased schizandrin content |
KR20130050554A (en) * | 2011-11-08 | 2013-05-16 | 정세영 | Manufacture of fermented schizandrae extract having gaba |
KR20130050510A (en) * | 2011-11-08 | 2013-05-16 | 정세영 | Manufacture of omija fermented beverage increased texture and biological activities using opuntia humifusa |
KR101396842B1 (en) | 2012-01-18 | 2014-05-19 | (주)비타바이오 | Fermentation product of schisandra chinensis and antibacterial and immune enhancing composition comprising the same |
KR101402031B1 (en) * | 2012-10-23 | 2014-06-02 | 계명대학교 산학협력단 | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 |
-
2014
- 2014-06-19 KR KR1020140074824A patent/KR101616187B1/en active IP Right Grant
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220010805A (en) | 2020-07-20 | 2022-01-27 | 농업회사법인 주식회사 아람바이오 | Method of manufacturing fermented beverage and distilled liquor |
KR20220133520A (en) | 2021-03-25 | 2022-10-05 | 계명대학교 산학협력단 | A novel Lactobacillus plantarum KS2020 strain having GABA production activity, and method for preparing red ginseng fermented product or lacquer tree fermented product containing high concentration γ-PGA and GABA using the strain |
KR102578454B1 (en) | 2022-07-15 | 2023-09-21 | 양일호 | Method for manufacturing black pine leaf fermented beverage using black omija fermented liquid and fermented black pine leaf fermented beverage produced thereby |
KR102668792B1 (en) * | 2023-01-03 | 2024-05-29 | 한국화학연구원 | Health functional food and pharmaceutical composition to help improve sleep quality |
Also Published As
Publication number | Publication date |
---|---|
KR20150145764A (en) | 2015-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101616187B1 (en) | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus | |
KR20120125042A (en) | A process for preparing a fermented broth of herbal medicine by combined microorganisms, a fermented broth prepared by the process, and a fermented food prepared by the fermented broth | |
KR101402031B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 | |
KR101826148B1 (en) | Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution | |
KR101792919B1 (en) | Method for manufacturing Aronia melanocarpa fortified with higher GABA content using Lactic acid bacteria | |
KR100943024B1 (en) | Bokbunja Rubus coreanus Miq. vinegar and its preparation method | |
CN111034996A (en) | Preparation method of apple enzyme functional beverage | |
KR101160231B1 (en) | A method for preparing Eucommia ulmoides vinegar composition | |
KR20080077970A (en) | Method of producing gaba-containing fermented product | |
KR101820709B1 (en) | Schizandra sap vinegar, and manufacturing method thereof | |
KR101944183B1 (en) | Method for manufacturing yeast starter containing apple pomace and Auricularia judae by mixed fermentation with lactic acid bacteria and yeast | |
KR20180009654A (en) | Preparation method of kiwifruit wine having enhanced flavor-taste by using mixed fermentation strains of Saccharomyces sp. and non-Saccharomyces sp. | |
KR101131069B1 (en) | Method for Preparing GABA-Containing Fermented Tomato Using Plant Originated Lactic Acid Bacteria with GABA-Producing Ability | |
KR101330274B1 (en) | Carbonated fermentate beverage and method of production there for using natural materials | |
Panda et al. | Bioprocessing of jackfruit (Artocarpus heterophyllus L.) pulp into wine: Technology, proximate composition and sensory evaluation | |
KR20200145127A (en) | Composition and method for yogurt with enhanced GABA using barley and yogurt produced by the same | |
KR101582728B1 (en) | Method for manufacturing Cornus Officinalis jam using GABA producing Lactobacillus and lactic acid apple pomace | |
KR100517062B1 (en) | Onion-vinegar and process for preperation thereof | |
KR102121839B1 (en) | Method for manufacturing functional fermented material of oriental melon with yeast and lactic acid bacteria | |
CN112522053A (en) | Preparation method of acerola cherry fruit wine | |
KR101200339B1 (en) | Wine utilizing the fruits of Pinkpap Borisu and method thereof | |
KR20190084917A (en) | Manufacturing method of vinegar using black rice and sugar fermented liquor and vinegar manufactured thereby | |
KR20200060568A (en) | Fermented product of red beet and manufacturing method thereof | |
KR102588661B1 (en) | A novel Lactobacillus plantarum KS2020 strain having GABA production activity, and method for preparing red ginseng fermented product or lacquer tree fermented product containing high concentration γ-PGA and GABA using the strain | |
Dygas et al. | Szyma nska |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20190416 Year of fee payment: 4 |